AstraZeneca

AstraZeneca returns to hypercholesterolemia via R&D pact with fresh-faced Chinese biotech
Fierce Biotech
Fri, 06/16/23 - 09:59 am
AstraZeneca
hypercholesterolemia
R&D
Cholesgen
Biopharma Confronts a Rising Tide of Ransomware Attacks
BioSpace
Wed, 06/14/23 - 10:11 am
cyberattacks
cybersecurity
ransomware
Eisai
Sun Pharma
Novartis
AstraZeneca
Merck
From farm to pharma: AstraZeneca inks renewable natural gas pact to shrink environmental footprint
Fierce Pharma
Tue, 06/13/23 - 10:50 pm
AstraZeneca
sustainability
carbon emissions
AstraZeneca Teams Up With Startup Quell in Type 1 Diabetes, IBD Cell Therapy Pact
MedCity News
Fri, 06/9/23 - 11:52 am
AstraZeneca
Quell Therapeutics
type 1 diabetes
IBD
cell therapy
AstraZeneca, Merck's Lynparza picks up new NICE recommendation
Fierce Pharma
Fri, 06/9/23 - 10:15 am
AstraZeneca
Merck
Lynparza
NICE
UK
ovarian cancer
fallopian tube cancer
EHA 2023 – Astrazeneca keeps up its complement defense
EP Vantage
Fri, 06/9/23 - 10:01 am
EHA
AstraZeneca
Alexion
Soliris
Ultomiris
Novartis
iptacopan
PNH
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
Stat
Thu, 06/8/23 - 09:47 pm
AstraZeneca
RSV
FDA
monoclonal antibodies
pediatric
Beyfortus
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
BioSpace
Thu, 06/8/23 - 09:26 pm
ASCO 2023
oncologists
cancer
AstraZeneca
Tagrisso
non-small cell lung cancer
Novartis
Kisqali
breast cancer
Merck
Keytruda
Moderna Therapeutics
cancer vaccine
FDA sets the stage for adcomm on Sanofi, AZ's RSV prospect later this week
Fierce Pharma
Wed, 06/7/23 - 09:42 pm
Sanofi
AstraZeneca
GSK
Pfizer
RSV
vaccines
FDA
ASCO 2023 – early first-line lung cancer data mined for datopotamab gold
EP Vantage
Wed, 06/7/23 - 10:02 am
ASCO 2023
Daiichi Sankyo
AstraZeneca
datopotamab deruxtecan
non-small cell lung cancer
ASCO 2023: AstraZeneca’s PD-1/TIGIT shows promise in checkpoint-exposed NSCLC
Clinical Trials Arena
Tue, 06/6/23 - 10:06 am
ASCO 2023
AstraZeneca
clinical trials
non-small cell lung cancer
rilvegostomig
ASCO: AstraZeneca Posts Strong Survival Data for Tagrisso in NSCLC Patients
BioSpace
Mon, 06/5/23 - 09:59 pm
ASCO 2023
AstraZeneca
Tagrisso
non-small cell lung cancer
AZ notches postmarket win for bleeding reversal agent Andexxa, plans to seek full approval
Fierce Pharma
Mon, 06/5/23 - 09:55 pm
AstraZeneca
bleeding reversal
AndexXa
AstraZeneca study points to new uses for targeted cancer drug Enhertu
BioPharma Dive
Mon, 06/5/23 - 11:32 am
ASCO 2023
AstraZeneca
Enhertu
uterine cancer
cervical cancer
ovarian cancer
bladder cancer
ASCO: AstraZeneca guns for wider ovarian cancer market with Imfinzi-Lynparza combo. Will the FDA buy the plan?
Fierce Pharma
Sun, 06/4/23 - 04:24 pm
ASCO 2023
AstraZeneca
Lynparza
Imfinzi
ovarian cancer
FDA clears narrow use of Lynparza in prostate cancer, continuing ‘shift’ on PARP drugs
BioPharma Dive
Thu, 06/1/23 - 11:53 am
AstraZeneca
Merck
Lynparza
prostate cancer
FDA
Liberate Bio taps former AZ drug-delivery head for CEO post
Medical Marketing and Media
Thu, 06/1/23 - 11:45 am
Liberate Bio
Pharma CEOs
AstraZeneca
Shawn Davis
AstraZeneca drops Skyrizi rival after seeing R&D timeline spiral
Fierce Biotech
Thu, 06/1/23 - 11:41 am
AstraZeneca
IBD
AbbVie
JNJ
brazikumab
Skyrizi
Stelara
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
AstraZeneca reports positive results from endometrial cancer therapy trial
Clinical Trials Arena
Mon, 05/29/23 - 12:24 pm
AstraZeneca
endometrial cancer
clinical trials
Imfinzi
Lynparza

Pages